This week, archaeologists identified depictions of the Milky Way galaxy in ancient Egyptian imagery. A mathematician found a ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

Current evidence shows limited benefit from additional immunotherapy in renal cell carcinoma patients previously treated with immune checkpoint inhibitors. Two large randomized trials yielded negative ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...

On top of this, he’ll be stuck in a shared cell with multiple inmates with no air conditioning with temperatures averaging at 97 degrees. Plus, he’ll be eating the same cheap food, costing $1. ...

One of the latest trends in Big Pharma dealmaking is T-cell engagers, and here AstraZeneca has had something of a head start, thanks to the acquisition of TeneoTwo in 2022. The main asset from ...

Ohio Gov. Mike DeWine announced his support for a bill that would ban student use of cell phones during the school day in Ohio."We all know screen time is very addictive, cell phone hazards go ...

S, Principal Investigator at A*STAR SRL are co-authors of the study. While the current study focuses on basal cell carcinoma (BCC), researchers believe the technology could also be adapted to ...

INVESTIGATORS AND CLINICIANS anticipate that the next wave of therapeutic approaches in renal cell carcinoma (RCC) will target hypoxia-inducible factor-2 (HIF-2), a transcription factor that is ...